Burrowing behavior is a potential non-invasive proxy for lesion development in a syngeneic murine model of endometriosis Megha Anchan, Samruddhi Deshpande, Atharvaraj Hande, Rooma Sinha, Jayesh Mudgal, K. Nandakumar, Rahul Dutta BMC Women S Health, 2026 Background Endometriosis (EM) is a persistent, chronic inflammatory condition associated with excruciating pelvic pain and infertility. The absence of a pre-clinical model that reliably replicates the clinical and functional hallmarks of human EM continues to limit progress in the domain. Furthermore, no rodent model developed to date has achieved a 100% incidence rate, compromising the reproducibility of existing models. Further, the inability to detect lesion development without sacrificing the animal presents a significant barrier for preclinical interventional trials designed to improve the management of EM. Methods We employed a non-invasive method based on the altered burrowing behavior of the animal to predict lesion development in the syngeneic mice EM model. We used the burrowing assay (BA) before dissection as a non-invasive behavioral marker to evaluate lesion progression across three distinct laboratory strains: C57BL/6j, BALB/c, and Swiss albino to account for variation due to genetic, immunological, and strain specificity. Results EM mice displayed a significant decline in burrowing activity compared to controls across all three strains. Based on BA performance, recipient mice were stratified into two groups: Recipients with a low burrow score (LB) and those with a high burrow score (HB). Additionally, LB mice exhibited decreased exploratory behavior and increased sensitivity to thermal pain. In contrast, HB mice had exploratory and thermal responses comparable to those of the control group. Post-dissection, LB mice were presented with ectopic lesions (LB+), whereas HB mice were lesion-negative (HB-). BA performance correlated strongly with lesion presence via ROC analysis, with a combined AUC of 0.883 (and an AUC of 1 for C57BL/6j), indicating excellent diagnostic accuracy of BA in predicting EM incidence. The combined approach of correlating burrowing behavior with other evoked behavioral responses and non-evoked provided a comprehensive assessment of EM disease progression. Conclusion To our knowledge, our research provides evidence for the feasibility of ethologically valid burrowing behaviour as a non-invasive predictor of EM incidence in the syngeneic mice model. Future preclinical drug research for EM management could leverage BA to identify and select only lesion-positive animals for intervention trials. This approach will enhance the translational value of EM research.
Computational identification of marine-derived inhibitors of Cyclophilin D and Protease-Activated Receptor-1 for the treatment of ischemic disease Veeresh Sadashivanavar, Manjunath Madalageri, Raghavendra Kinnal, Krishnadas Nandakumar, Ruchi Verma, K Sreedhara Ranganath Pai Journal of Molecular Graphics and Modelling, 2026 Myocardial infarction (MI) and stroke are examples of ischaemic diseases that continue to pose serious health risks since few specific treatments address the underlying molecular causes of these conditions, which include pathological thrombosis and mitochondrial dysfunction. In order to close this gap, we used an integrated in-silico method to find strong inhibitors for Protease-Activated Receptor-1 (PAR-1) and Cyclophilin D (CypD) from the structurally diverse CMNPD marine natural product library. To account for protein flexibility, our method combines High Throughput Virtual Screening (HTVS), Standard Precision (SP), and Extra Precision (XP) docking with meticulous Induced Fit Docking (IFD). After undergoing 500 ns Molecular Dynamics (MD) simulations, the best candidate compounds showed remarkable structural stability with RMSD values between 0.6 and 1.7 Å. Strong binding affinities were found by thermal MM-GBSA calculations, with CMNPD29955 showing a ΔG of –63.146 kcal/mol towards CypD and CMNPD3572 and CMNPD22037 showing ΔG values of –96.24 and –98.092 kcal/mol against PAR-1, respectively. Lead molecules of each target were found to have important hydrophobic and hydrogen bonding interactions with crucial active site residues in MD modelling. The dynamic stability and energetic favorability of these chemicals were further confirmed by complementary techniques, including WaterMap, Principal Component Analysis (PCA), and Free Energy Landscape (FEL). In addition to CMNPD3572 and CMNPD22037 as potential PAR-1 antagonists, this work emphasises CMNPD29955 as a new lead inhibitor that targets mitochondrial dysfunction via CypD. To transform computational insights into effective and complementary therapeutic alternatives, lead optimisation, experimental validation, and preclinical assessment of these special marine-derived molecules will be crucial in the future. • By focusing on thrombosis (Protease-Activated Receptor-1 (PAR-1)) and mitochondrial dysfunction (Cyclophilin D (CypD)), an integrated multi-stage in-silico workflow was used to find new treatments for ischemic diseases. • Lead compounds demonstrated excellent dynamic stability during 500 ns molecular dynamics simulations, with RMSD values consistently between 0.6 and 1.7 Å. • MM-GBSA binding free energy calculations revealed strong affinities, including CMNPD3572 and CMNPD22037 for PAR-1 (ΔG ≈ -96 to -98 kcal/mol) and CMNPD29955 for CypD (ΔG ≈ −63 kcal/mol). • Further advanced analyses, such as WaterMap, PCA and Free Energy Landscape studies, confirmed favorable hydration thermodynamics along with stable conformational dynamics and energetically preferred binding states. • CMNPD29955 emerged as a novel marine-derived CypD inhibitor. CMNPD3572 and CMNPD22037 are as PAR-1 inhibitors highlighting a promising strategy to mitigate mitochondrial dysfunction alongside PAR-1–mediated thrombosis in ischemic disorders.
Reversal of diabetes-associated cognitive impairment through modulation of BDNF, insulin, and NF-κB pathways by a marketed herbal formulation Nabeel Kinattingal, Venugopal Bovilla, Seema Mehdi, Mahadevaswamy G. Kuruburu, K. Nandakumar, Santhepete N. Manjula 3 Biotech, 2026 Diabetes-associated cognitive impairment is a recognized complication of chronic hyperglycemia affecting learning and memory. We investigated whether Tamarindus indica seed extract (TSE) and Diabecon, a marketed herbal formulation (MHF), could reverse diabetes-associated cognitive decline in a high-fat diet (HFD) and streptozotocin (STZ) induced type 2 diabetic rat model. Diabetic rats were treated with pioglitazone (standard), TSE (250 mg/kg), or MHF (500 mg/kg) for four weeks. Antioxidant activity and phenolic content of TSE and MHF were evaluated using DPPH radical scavenging and ferric-reducing antioxidant power (FRAP) assays, and animals were assessed for learning and memory using the Barnes maze and novel object recognition tests. Hippocampal biochemical analysis revealed reduced antioxidant levels, decreased BDNF and insulin levels, and increased oxidative stress and inflammatory cytokines in diabetic rats. Behavioral assessments demonstrated significant cognitive impairment in HFD–STZ diabetic rats, evidenced by increased escape latency time and reduced preference index. Treatment with MHF significantly improved cognitive performance compared with untreated diabetic animals, whereas TSE showed limited effects. Biochemical analysis revealed that diabetes induction reduced hippocampal BDNF and insulin levels and increased oxidative stress and inflammatory cytokines. MHF treatment significantly restored BDNF and insulin levels, reduced lipid peroxidation, enhanced endogenous antioxidant enzyme activity, and suppressed inflammatory mediators. Western blot analysis further demonstrated modulation of NF-κB and Nrf2 signaling pathways in the hippocampus following MHF treatment. These findings suggest that the marketed herbal formulation Diabecon may alleviate diabetes-associated cognitive decline by reducing oxidative stress and inflammation while improving neurotrophic signaling.
Preclinical evidence for digoxin's anti-tumor activity through HIF-1α pathways: Systematic review and meta-analysis Dhanya Bolar, Gollapalle Lakshminarayanashastry Viswanatha, Chamallamudi Mallikarjuna Rao, Shylaja Hanumanthappa, Krishnadas Nandakumar, Pawan Ganesh Nayak Pharmacological Research Natural Products, 2026 This systematic review and meta-analysis was aimed to synthesize existing preclinical evidence on digoxin's anti-tumor effects via HIF-1α inhibition. This study was conducted as per PRISMA 2020 guidelines. A systematic literature search was conducted using PubMed/Medline, EMBASE, and Google Scholar, and based on the inclusion and exclusion criteria, a total of 13 studies were selected. The meta-analysis performed on the included studies revealed that the digoxin treatment decreased the tumor volume (IV:-1.40(-1.89 to -0.91) at 95% CI, p<0.00001, I 2 =42%), H I F-1α (IV:-2.43(-4.07 to -0.78) at 95% CI, p=0.004, I 2 = 62%), VEGF (IV:-1.14(-1.91 to -0.36) at 95% CI, p=0.004, I 2 = 0%), and GLUT-1 (IV: 1.57(-2.57 to -0.57) at 95% CI, p=0.002 I 2 = 0%), but had no statistically significant reduction in the tumor weight (IV:-0.31(-0.69 to 0.07), 95% CI, p=0.11, I 2 =98%), and CD31 marker (IV:-1.15(-3.10 to 0.79) at 95% CI, p=0.25, I 2 =71%) and has no effect on the animal survival rate (IV:6.46(-0.93 to 13.86) at 95% CI, p=0.09, I 2 =86%) compared to the control. Conclusions: In summary, the available moderate weight of evidence suggests that digoxin possesses potential anti-tumor effects via HIF-1α pathways. However, considering the pitfalls associated with the existing studies, there is a scope for conducting more robust pre-clinical studies. Further, randomized controlled trials in humans are essential to evaluate and validate the antitumor effect of digoxin. • Meta-analysis shows digoxin reduces tumor growth in preclinical models • Digoxin targets hypoxia inducible factor (HIF-1α) driving tumor growth pathways • Associated with reduced tumor size and key signals linked to growth • No consistent effect on survival or tumor weight across studies • Further preclinical studies and human trials are needed for validation
Gemini surfactant-stabilized cubosomes for enhanced topical delivery of 5-fluorouracil in cutaneous squamous cell carcinoma Ruchira Raychaudhuri, Ajinkya Nitin Nikam, Naitik Jain, Abhisheik Eedara, Neha Kandpal, Rajdeep Ray, Krishnadas Nandakumar, Sai Balaji Andugulapati, Srinivas Mutalik International Journal of Pharmaceutics X, 2026 Cutaneous squamous cell carcinoma (cSCC) is a prevalent non-melanoma skin cancer. Topical chemotherapy offers a non-invasive alternative to surgical treatments, yet the therapeutic efficacy of conventional agents like 5-fluorouracil is hindered by poor skin permeability and systemic side effects. In this study, we developed a gemini-surfactant-stabilized cubosomal gel (OF12-GEL) for enhanced topical delivery of 5-fluorouracil. The optimized cubosomes (OF12) exhibited a particle size of 134.4 nm, PDI 0.23, zeta potential +76.1 mV, and 51.3% entrapment efficiency. OF12-GEL achieved 41% release at 24 h and increased skin deposition to 323.7 μg/cm 2 , nearly 3-fold higher than free 5-FU (114.1 μg/cm 2 ). In A431 cells, OF12 showed a lower IC₅₀ (0.77 μg/mL) than free 5-FU (1.15 μg/mL) and enhanced cellular uptake. In vivo , OF12-GEL significantly suppressed tumor growth in both DMBA-induced SCC rats and A431 xenograft mice, reducing tumor volume by and improving survival to 60%, and markedly downregulating BCL-2, Ki67, TNF-α, and ABCB1. OF12-GEL was non-irritant (PII = 0.33). These findings demonstrate a potent, safe, and targeted nanocarrier-based topical therapy for cSCC.
Reverse Phase High Performance Liquid Chromatography Method for the Estimation of Mangiferin in Nano Formulations: Development and Optimization by Analytical Quality-by-Design Akshatha P. Kamath, Lalit Kumar, Srinivas Mutalik, Pawan Ganesh Nayak, Krishnadas Nandakumar ACS Omega, 2026 A novel reverse-phase high-performance liquid chromatography (RP-HPLC) method was developed and optimized for the estimation of Mangiferin (MGF) by employing a Quality by Design (QbD) approach. Preliminary method screening was done by the Taguchi OA, followed by using a Box-Behnken Design (BBD), enabling systematic evaluation of critical factors with a reduced number of experimental runs. The model efficiently established significant correlations between selected variables and analytical responses, thereby enhancing the method's robustness and reliability. Chromatographic separation was achieved on a Hyperclone C18 column (4.6 × 250 mm, 5 μm) using an isocratic mobile phase consisting of phosphate buffer (pH 3.2) and acetonitrile (30%) + methanol (70%) in a 78:22% v/v ratio, at a flow rate of 1.0 mL/min. Detection was performed using a photodiode array detector at 258 nm. The method was validated in accordance with ICH Q2-(R2) guidelines. Validation parameters, including system suitability, linearity, accuracy, precision, robustness, sensitivity, and solution stability, were found within acceptable limits. The proposed method was successfully applied for the analysis of the stability study of MGF and to analyze the release kinetics of MGF SLNs, formulated via high-pressure homogenization and the sonication technique. The results confirm the applicability of the developed RP-HPLC method for routine quality control of combination nanocarrier systems.
New Insights on Heat Shock Proteins as Regulators of Reactive Oxygen Species Across Various Stressors in Diseases Paka Sravan Kumar, Triveni Kodi, Adarsh Gopinathan, Bharath Harohalli Byregowda, Krishnadas Nandakumar, Anoop Kishore Cell Biochemistry and Function, 2026 Living beings are persistently challenged by stress. Stress can be induced by internal stressors and external stressors. External stressors, including radiation, heat, heavy metals, nutritional imbalances, infections, and psychological stress, can induce protein denaturation, leading to misfolded or aggregated proteins. These stressors often cause overproduction of reactive oxygen species (ROS), leading to oxidative stress following inflammation. This cascade causes and accelerates various disorders, such as diabetes, neurodegenerative, respiratory, cardiovascular, autoimmune. This disease, in turn, becomes internal stressors, perpetuating cellular dysfunction through sustained ROS production and chronic inflammation, creating a self‐amplifying cycle that can lead to degenerative outcomes and organ failure. To cope with these stressors, cells initiate defense and protective mechanisms like antioxidant and heat shock proteins (HSPs). However, HSPs rapidly work to correct protein misfolding, mitigate oxidative damage, and reduce inflammation in response to external and internal stressors. HSPs increase the cell's efficiency to lower ROS levels and maintain the redox balance. On the other hand, cellular antioxidant regulatory role of HSPs includes suppressing apoptosis, modulating inflammatory signaling pathways (such as NF‐κB, MAPK, JAK‐SAT), inflammatory mediators (including TNF‐α, IL‐1β, IL‐6) and maintaining proteostasis, Therefore, HSPs play a significant role in cellular survival and function under stress. However, targeting HSPs represents a promising future strategy for managing stress related conditions with a variety of diseases.
Morin protects against palmitic acid-induced diabetic cardiomyopathy via SIRT6 activation and mitochondrial preservation K. P 10.7324/JAPS.2026.261812, P. V Anuranjana, Krupa Thankam George, Krishnaprasad Baby, Fathima Beegum, Navjot Kanwar, Nitesh Kumar, Krishnadas Nandakumar, Abhinav Kanwal Journal of Applied Pharmaceutical Science, 2026 Diabetic cardiomyopathy (DCM) is a serious diabetes complication marked by cardiac dysfunction and structural abnormalities. Mitochondrial dysfunction, driven by lipotoxicity and glucotoxicity, is central to DCM pathogenesis. SIRT6, a sirtuin family protein, is a potential therapeutic target due to its role in mitochondrial protection. This study explored morin, a natural flavonoid, as a SIRT6 activator to protect against palmitic acid-induced cardiomyopathy in H9c2 cells. In silico molecular docking identified morin as a potential SIRT6 activator with strong binding affinity, especially at residues ASP116 and PHE82. In vitro studies in H9c2 cardiomyoblasts confirmed morin’s protective effects against palmitic acid-induced toxicity. Morin pretreatment improved cell viability and reduced cytotoxicity. It enhanced glucose uptake, preserved mitochondrial membrane potential, and protected against mitochondrial damage. Morin also decreased reactive oxygen species (ROS), and lowered early and late apoptosis rates, showing strong anti-apoptotic effects. Additionally, morin upregulated SIRT6 and OPA1 expression, key genes for mitochondrial function and protection. These results suggest morin’s cardioprotective effects involve SIRT6 activation, mitochondrial protection, antioxidant activity, and anti-apoptotic mechanisms. By upregulating SIRT6 and OPA1, morin may counteract mitochondrial dysfunction in DCM. This study highlights morin’s therapeutic potential as a natural compound for DCM treatment, warranting further preclinical and clinical research.
Sesamol and health - A comprehensive review Abhishek Shah, Richard Lobo, Nandakumar Krishnadas, Raviteja Surubhotla Indian Journal of Pharmaceutical Education and Research, 2019
Catechin, an active constituent of green tea, preserves skeletal muscle activity in dexamethasone induced cachexia by increasing acetylcholine sensitivity in muscles of wistar rats Indian Journal of Experimental Biology, 2018
Evaluation of antidiarrhoeal effect of acetone extract fraction from the stem bark of T. Populnea International Journal of Pharmacognosy and Phytochemical Research, 2016
Antimicrobial, anticancer and cytotoxic activities of acetone extract fraction from stem bark of Thespesia populnea (Linn.) Research Journal of Pharmaceutical Biological and Chemical Sciences, 2016
Monitoring of adverse reactions in geriatric south Indian patients in a tertiary care teaching hospital: A prospective study Research Journal of Pharmaceutical Biological and Chemical Sciences, 2016
Hypoglycaemic effects of alcoholic root extract of Borassus flabellifer (Linn.) in normal and diabetic rats Pakistan Journal of Pharmaceutical Sciences, 2013
Anxiolytic and anticonvulsant activity of aqueous extract of stem bark of Erythrina variegata in rodents International Journal of Pharmtech Research, 2010
Anxiolytic activity of root extracts of Cardiospermum halicacabum in mice Internet Journal of Pharmacology, 2009
Analgesic and antiinflammatory activity of leaf extracts of Commiphora caudata in rodents Pharmacologyonline, 2009
Immunomodulatory activities of Wrightia tinctoria (Roxb.) R. Br bark extracts Pharmacologyonline, 2009
Antiulcer activity of stem extracts of Tinospora malabarica (Lamk.) Pharmacologyonline, 2009
Antidiarrheal activity of stem bark extracts od Spathodea companulata in rodents Pharmacologyonline, 2009
Antidiarrheal activity of methanolic extracts of seeds of Lepidium sativum Journal of Natural Remedies, 2009
Hepatoprotective activity of ethanolic and aqueous extract of Terminalia belerica in rats Pharmacologyonline, 2008
Preliminary phytochemical studies and antimicrobial activity of stem bark of Thespesia populnea Pharmacologyonline, 2008
Synthesis, β-adrenergic receptor binding and antihypertensive potential of vanillin-derived phenoxypropanolamines Indian Journal of Chemistry Section B Organic and Medicinal Chemistry, 2008
Comparative evaluation of analgesic, anti-inflammatory and antipyretic activity of leaves, stem and roots of Lantan camara Pharmacologyonline, 2008
Antidiarrheal activity of alcoholic and aqueous extracts of stem bark of Thespesia populnea in rodents Pharmacologyonline, 2007
Anxiolytic and anti convulsant activity of alcoholic extract of heartwood of Aquilaria agallocha roxb (thymelaeceae) in mice Pharmacologyonline, 2007
Anxiolytic and anticonvulsant activity of alcoholic extract of heartwood of Aquilaria agallocha roxb, (Thymelaeceae) in mice Pharmacologyonline, 2007
Hepatoprotective effect of root extracts of Tylophora Indica (wight & arn) against ethanol induced liver damage in rats Toxicology International, 2007
Analgesic and anti-inflammatory activity of heartwood of Aquilaria agallocha in laboratory animals Pharmacologyonline, 2007
A study on CNS effects of milk extract of nuts of Semecarpus anacardium. Linn, (Anacardiaceae) Pharmacologyonline, 2007
Antihypertensive effect of newly synthesized acyl amino substituted propanolamine derivatives, DPJ 890 and DPJ 955 in rats [1] Indian Journal of Pharmacology, 2004
In Vitro Reaction Phenotyping and Projection of Drug Interactions Mediated by Cytochrome P450 Enzymes for Central Nervous System Drugs as Victims: Implications for Safety in … VRC Palacharla, R Nirogi, N Kumar, P Jayarajan, HR Pantangi, S Petlu, ... Drug Metabolism and Disposition, 100295 , 2026 2026
Preclinical evidence for digoxin’s anti-tumor activity through HIF-1α pathways: Systematic review and meta-analysis D Bolar, GL Viswanatha, CM Rao, S Hanumanthappa, K Nandakumar, ... Pharmacological Research-Natural Products, 100619 , 2026 2026
Reverse Phase High Performance Liquid Chromatography Method for the Estimation of Mangiferin in Nano Formulations: Development and Optimization by Analytical Quality-by-Design AP Kamath, L Kumar, S Mutalik, PG Nayak, K Nandakumar ACS omega 11 (11), 18067-18079 , 2026 2026
Insights into effective protocol structuring: optimizing dosing strategies, experimental design, and statistical approaches P Balakumar, K Nandakumar, G Jagadeesh Pharmacology & Therapeutics, 109015 , 2026 2026 Citations: 1
Re‐evaluating the forced swim test: ethical, scientific, and regulatory drivers for validated alternatives P Barai, V Pogakula, JS Sandhu, A Parida, N Krishnadas, GL Viswanatha Frontiers in Animal Science 7, 1692092 , 2026 2026
Computational identification of marine-derived inhibitors of Cyclophilin D and Protease-Activated Receptor-1 for the treatment of ischemic disease V Sadashivanavar, M Madalageri, R Kinnal, K Nandakumar, R Verma, ... Journal of Molecular Graphics and Modelling, 109329 , 2026 2026
Gemini surfactant-stabilized cubosomes for enhanced topical delivery of 5-fluorouracil in cutaneous squamous cell carcinoma R Raychaudhuri, AN Nikam, N Jain, A Eedara, N Kandpal, R Ray, ... International Journal of Pharmaceutics: X, 100504 , 2026 2026 Citations: 1
New Insights on Heat Shock Proteins as Regulators of Reactive Oxygen Species Across Various Stressors in Diseases PS Kumar, T Kodi, A Gopinathan, BH Byregowda, K Nandakumar, ... Cell Biochemistry and Function 44 (2), e70173 , 2026 2026 Citations: 1
Morin protects against palmitic acid-induced diabetic cardiomyopathy via SIRT6 activation and mitochondrial preservation KP Divya, PV Anuranjana, KT George, K Baby, F Beegum, N Kanwar, ... Journal of Applied Pharmaceutical Science 16 (2), 089-102 , 2026 2026
Burrowing behavior is a potential non-invasive proxy for lesion development in a syngeneic murine model of endometriosis M Anchan, S Deshpande, A Hande, R Sinha, J Mudgal, K Nandakumar, ... BMC Women's Health , 2025 2025 Citations: 1
Systematic review and meta-analysis of Tanacetum parthenium : evaluating its efficacy in migraine relief V Nelaturi, GL Viswanatha, RR Shenoy, S Khanna, N Krishnadas Natural Product Research, 1-8 , 2025 2025 Citations: 1
Alpha lipoic acid: advancing insights in diabetic neuropathy through updated systematic review and meta-analysis S Das, GL Viswanatha, K Nandakumar, A Kishore, S Hanumanthappa Exploration of Neuroprotective Therapy 5, 1004125 , 2025 2025
Mangiferin‐Encapsulated Lipid Carriers: Innovative strategy for Enhanced Brain Delivery in Alzheimer's Therapy AP Kamath, N Krishnadas, PG Nayak Alzheimer's & Dementia 21, e108327 , 2025 2025
Enhanced Anticancer Activity in HR+/HER2+ Breast Cancer Cells Using Trastuzumab-Conjugated Liposomes co-loaded with siRNA and Tamoxifen G Kumar, F Begum, PC Gurram, BH B, P Mullick, K Nandakumar, ... BioNanoScience 15 (4), 527 , 2025 2025 Citations: 2
Design and Characterization of Novel Gastroretentive Drug Delivery System of Antibiotics and Piperine for the Eradication of H. pylori Infection A Gupta, M Saha, SS Kunkalienkar, A Ghurye, S Verma, J Joshi, A Jha, ... Molecular Pharmaceutics 22 (12), 7641-7663 , 2025 2025 Citations: 2
Resveratrol, a calorie restriction mimetic, protects AlCl 3 -induced neurotoxicity and cognitive deficits in rats via inhibition of oxidative stress VS Benade, P Jayarajan, N Krishnadas, R Nirogi Naunyn-Schmiedeberg's Archives of Pharmacology 398 (11), 15983-16001 , 2025 2025 Citations: 2
Design and development of ultra-flexible combisomal gel for non-invasive delivery of 4-hydroxytamoxifen and hesperidin in breast cancer treatment C Lizzie Lobo, A S, M Mahadev, A Shetty, S Hebbar, N Krishnadas, I Anna, ... Journal of Dispersion Science and Technology, 1-18 , 2025 2025
Nanoemulsion as a promising drug delivery strategy for effective eradication of Helicobacter pylori: current insights M Saha, A Gupta, S Kunkalienkar, N Dhas, S Shetty, A Gupta, S Mutalik, ... Drug Delivery and Translational Research, 1-28 , 2025 2025 Citations: 9
Role of Wnt/beta-catenin pathway in cancer drug resistance: Insights into molecular aspects of major solid tumors (vol. 729, 150348, 2024) C Samant, R Kale, K Pai, S Ranganath, K Nandakumar, M Bhonde BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 778 , 2025 2025
Transferrin conjugated pH/NIR-responsive black phosphorus nanoplatform: A novel multimodal approach for breast cancer theranostics S Soman, S Kulkarni, J John, M Paul, K Nandakumar, S Biswas, ... International Journal of Pharmaceutics: X, 100364 , 2025 2025 Citations: 2
MOST CITED SCHOLAR PUBLICATIONS
COVID-19: emergence, spread, possible treatments, and global burden R Keni, A Alexander, PG Nayak, J Mudgal, K Nandakumar Frontiers in public health 8, 216 , 2020 2020 Citations: 348
Hepatoprotective activity of alcoholic and aqueous extracts of leaves of Tylophora indica (Linn.) in rats V Gujrati, N Patel, VN Rao, K Nandakumar, TS Gouda, MD Shalam, ... Indian journal of pharmacology 39 (1), 43-47 , 2007 2007 Citations: 135
New insights on NLRP3 inflammasome: mechanisms of activation, inhibition, and epigenetic regulation T Kodi, R Sankhe, A Gopinathan, K Nandakumar, A Kishore Journal of Neuroimmune Pharmacology 19 (1), 7 , 2024 2024 Citations: 126
Rutin protects against neuronal damage in vitro and ameliorates doxorubicin-induced memory deficits in vivo in Wistar rats GV Ramalingayya, SP Cheruku, PG Nayak, A Kishore, R Shenoy, ... Drug design, development and therapy, 1011-1026 , 2017 2017 Citations: 115
Impact of caffeic acid on aluminium chloride-induced dementia in rats KA Khan, N Kumar, PG Nayak, M Nampoothiri, RR Shenoy, N Krishnadas, ... Journal of Pharmacy and Pharmacology 65 (12), 1745-1752 , 2013 2013 Citations: 112
Anti-inflammatory activity of Terminalia paniculata bark extract against acute and chronic inflammation in rats S Talwar, K Nandakumar, PG Nayak, P Bansal, J Mudgal, V Mor, CM Rao, ... Journal of ethnopharmacology 134 (2), 323-328 , 2011 2011 Citations: 111
A comprehensive review on Sesamum indicum L.: Botanical, ethnopharmacological, phytochemical, and pharmacological aspects A Mili, S Das, K Nandakumar, R Lobo Journal of Ethnopharmacology 281, 114503 , 2021 2021 Citations: 99
Treatment of H. pylori infection and gastric ulcer: Need for novel Pharmaceutical formulation A Gupta, S Shetty, S Mutalik, EM Mathew, A Jha, B Mishra, S Rajpurohit, ... Heliyon 9 (10) , 2023 2023 Citations: 96
Sesamol-loaded PLGA nanosuspension for accelerating wound healing in diabetic foot ulcer in rats K Gourishetti, R Keni, PG Nayak, SR Jitta, NA Bhaskaran, L Kumar, ... International journal of nanomedicine, 9265-9282 , 2020 2020 Citations: 88
Modulatory role of vitamins A, B3, C, D, and E on skin health, immunity, microbiome, and diseases M Joshi, P Hiremath, J John, N Ranadive, K Nandakumar, J Mudgal Pharmacological Reports 75 (5), 1096-1114 , 2023 2023 Citations: 82
Hypoglycaemic and anti-diabetic activity of stem bark extracts Erythrina indica in normal and alloxan-induced diabetic rats AY Kumar, K Nandakumar, M Handral, S Talwar, D Dhayabaran Saudi Pharmaceutical Journal 19 (1), 35-42 , 2011 2011 Citations: 76
Long circulating PEGylated-chitosan nanoparticles of rosuvastatin calcium: development and in vitro and in vivo evaluations MR Hirpara, J Manikkath, K Sivakumar, RS Managuli, K Gourishetti, ... International journal of biological macromolecules 107, 2190-2200 , 2018 2018 Citations: 74
Animal models of chemotherapy-induced cognitive decline in preclinical drug development J John, M Kinra, J Mudgal, GL Viswanatha, K Nandakumar Psychopharmacology 238 (11), 3025-3053 , 2021 2021 Citations: 68
Mechanistic targets for BPH and prostate cancer–a review A Shah, AA Shah, N K, R Lobo Reviews on Environmental Health 36 (2), 261-270 , 2021 2021 Citations: 68
Catechin ameliorates doxorubicin-induced neuronal cytotoxicity in in vitro and episodic memory deficit in in vivo in Wistar rats SP Cheruku, GV Ramalingayya, MR Chamallamudi, S Biswas, ... Cytotechnology 70 (1), 245-259 , 2018 2018 Citations: 66
Antioxidant and antimutagenic activities of bark extract of Terminalia arjuna GL shastry Viswanatha, SK Vaidya, N Krishnadas, S Rangappa Asian Pacific Journal of Tropical Medicine 3 (12), 965-970 , 2010 2010 Citations: 66
Naringin and rutin alleviates episodic memory deficits in two differentially challenged object recognition tasks GV Ramalingayya, M Nampoothiri, PG Nayak, A Kishore, RR Shenoy, ... Pharmacognosy Magazine 12 (Suppl 1), S63 , 2016 2016 Citations: 61
Vasorelaxant effect in rat aortic rings through calcium channel blockage: A preliminary in vitro assessment of a 1, 3, 4-oxadiazole derivative GR Bankar, K Nandakumar, PG Nayak, A Thakur, MR Chamallamudi, ... Chemico-Biological Interactions 181 (3), 377-382 , 2009 2009 Citations: 60
An appraisal of current pharmacological perspectives of sesamol: A review B Bosebabu, SP Cheruku, MR Chamallamudi, M Nampoothiri, ... Mini reviews in medicinal chemistry 20 (11), 988-1000 , 2020 2020 Citations: 59
Catechin ameliorates depressive symptoms in Sprague Dawley rats subjected to chronic unpredictable mild stress by decreasing oxidative stress A Rai, M Gill, M Kinra, R Shetty, N Krishnadas, CM Rao, S Sumalatha, ... Biomedical reports 11 (2), 79-84 , 2019 2019 Citations: 57